Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autoimmune disorder which does not meet classification criteria used to establish the presence of other well-defined connective tissue diseases.
Features include common findings: Anti-dsDNA antibody positivity, Anti-ribosome Po antibody positivity, and Anti-Ro52/TRIM21 antibody positivity.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 3 | Anti-dsDNA antibody positivity, Anti-ribosome Po antibody positivity, Anti-Ro52/TRIM21 antibody positivity |
Biomarker and diagnostic research for undifferentiated connective tissue syndrome has been reported in the published literature.
Phenotype severity distribution: 3 common features.
4 clinical trials registered, 3 recruiting. Interventions under study include other interventions. Pipeline includes 2 NA. Research is primarily sponsored by academic and government institutions.
76 publications have been identified in PubMed for undifferentiated connective tissue syndrome. Research spans Case Report / Case Series (36%), Epidemiology / Natural History (28%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 27 |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 9:47 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression | 21 | 28% |
Testing and diagnosis research | 12 | 16% |
Research summaries | 10 | 13% |
Laboratory research | 3 | 4% |
Clinical study results | 2 | 3% |
Other research | 1 | 1% |
Marwa K (2026). [PMID: 34283427](https://pubmed.ncbi.nlm.nih.gov/34283427/). *Unknown Journal*. [Review / Meta-Analysis]
Apaydin H (2026). [PMID: 41670330](https://pubmed.ncbi.nlm.nih.gov/41670330/). *Mod Rheumatol*. [Epidemiology / Natural History]
Wang B (2026). [PMID: 41883959](https://pubmed.ncbi.nlm.nih.gov/41883959/). *Front Oncol*. [Case Report / Case Series]
Ji T (2026). [PMID: 41247110](https://pubmed.ncbi.nlm.nih.gov/41247110/). *Rheumatology (Oxford)*. [Basic Science / Preclinical]
Wielosz E (2026). [PMID: 41909065](https://pubmed.ncbi.nlm.nih.gov/41909065/). *Reumatologia*. [Review / Meta-Analysis]
Tse JD (2026). [PMID: 41593546](https://pubmed.ncbi.nlm.nih.gov/41593546/). *BMC Nephrol*. [Case Report / Case Series]
Sapkota B (2026). [PMID: 31194355](https://pubmed.ncbi.nlm.nih.gov/31194355/). *Unknown Journal*. [Review / Meta-Analysis]
Papamichail GV (2026). [PMID: 41872662](https://pubmed.ncbi.nlm.nih.gov/41872662/). *Clin Rheumatol*. [Epidemiology / Natural History]
Du M (2026). [PMID: 41580474](https://pubmed.ncbi.nlm.nih.gov/41580474/). *Sci Rep*. [Epidemiology / Natural History]
Pratama MZ (2026). [PMID: 42178941](https://pubmed.ncbi.nlm.nih.gov/42178941/). *Int J Rheum Dis*. [Diagnostic / Biomarker]